<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-P19</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-P19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>The impact of radiologists&#x02019; expertise on screen result decisions in CT lung cancer screening</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Heuvelmans</surname><given-names>MA</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>m.a.heuvelmans@umcg.nl</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Oudkerk</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>de Jong</surname><given-names>PA</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Mali</surname><given-names>WPTM</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Groen</surname><given-names>HJM</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Vliegenthart</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Center for Medical Imaging &#x02013; North East Netherlands, Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands</aff><aff id="I2"><label>2</label>Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands</aff><aff id="I3"><label>3</label>Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>P19</fpage><lpage>P19</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Heuvelmans et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Heuvelmans et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/P19"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title>Aim</title><p>To evaluate the impact of radiological expertise on screen result decisions made in a CT lung cancer screening trial.</p></sec><sec sec-type="methods"><title>Methods</title><p>In the Dutch-Belgian randomized lung cancer screening trial (NELSON), the baseline CT screen result was based on the lung nodule with largest volume. According to the protocol, nodule volume&#x0003c;50mm3, 50-500mm3 and &#x0003e;500mm3 led to a negative, indeterminate and positive screen result, respectively. The protocol, however, allowed radiologists to manually adjust screen result in case of high suspicion of benign or malignant nodule nature. In this study, all participants whose baseline CT result was based on a solid nodule were included. Adjustments by radiologists at baseline were evaluated. Histology was the reference for diagnosis, or, to confirm benignity, stability on subsequent CT scans.</p></sec><sec sec-type="results"><title>Results</title><p>3,268 participants (2,759 male, median age 58.0-years) were included. In 189 participants (5.8%) the initial baseline screen result was adjusted by the radiologist. Adjustment was downwards from positive or indeterminate to negative in two and 118 participants, respectively, and from positive to indeterminate in 64 participants. None of these nodules turned out malignant. In five participants (2.6%) the screen result was adjusted upwards from negative to indeterminate (N=1) or indeterminate to positive (N=4); two nodules (40%) were malignant.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In about one-in-twenty cases of baseline lung cancer screening, nodules were reclassified by the radiologist (97.4% downwards), leading to reduction of false-positive and false-negative screen results.</p></sec></body></article>
